• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

2.550 -0.020 (-0.78%)
Streaming Delayed Price Updated: 10:45 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Spero Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Spero Therapeutics Inc (NASDAQ:SPRO) Posts Q3 Revenue and EPS Beat ↗
November 13, 2025
Spero Therapeutics (SPRO) smashed Q3 2025 earnings, with revenue of $5.44M beating $0 estimates and a narrower EPS loss of -$0.13. 
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
 
Via Benzinga
News headline image
Insights Ahead: Spero Therapeutics's Quarterly Earnings ↗
November 12, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
August 12, 2025
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
August 12, 2025
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
Earnings Outlook For Spero Therapeutics ↗
August 11, 2025
 
Via Benzinga
News headline image
An Overview of Spero Therapeutics's Earnings ↗
May 12, 2025
 
Via Benzinga
News headline image
A Glimpse of Spero Therapeutics's Earnings Potential ↗
March 26, 2025
 
Via Benzinga
News headline image
SPERO THERAPEUTICS INC (NASDAQ:SPRO) Reports Mixed Q2 2025 Results with Revenue Beat but Stock Decline ↗
August 12, 2025
SPERO Therapeutics (SPRO) reported Q2 2025 results with $14.19M revenue, beating estimates, but shares fell 6.8%. Phase 3 trial for tebipenem HBr halted early for efficacy. 
Via Chartmill
News headline image
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗
June 09, 2025
 
Via Benzinga
News headline image
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May ↗
May 31, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
May 30, 2025
 
Via Benzinga
News headline image
The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts ↗
January 30, 2025
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Spero Therapeutics ↗
December 20, 2024
 
Via Benzinga
News headline image
Spero Therapeutics's Earnings Outlook ↗
November 13, 2024
 
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
 
Via Benzinga
News headline image
Unusual volume stocks in Friday's session ↗
May 30, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
May 29, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 28, 2025
 
Via Benzinga
News headline image
These stocks are making the most noise in today's session. ↗
May 28, 2025
Stay updated with the latest market activity on Wednesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
News headline image
Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
May 28, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
May 28, 2025
 
Via Benzinga
News headline image
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast ↗
May 28, 2025
Via Benzinga
News headline image
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday? ↗
May 28, 2025
GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral carbapenem in the U.S. 
Via Benzinga
News headline image
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings ↗
May 28, 2025
 
Via Benzinga
News headline image
GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled ↗
May 28, 2025
The early stop follows the trial meeting its primary endpoint of non-inferiority of Tebipenem HBr compared to an intravenous medicine in hospitalised adult patients with cUTI. 
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
May 28, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For March 27, 2025 ↗
March 27, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2024 ↗
November 14, 2024
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap